Meredith Siler
Adult Health · Kernersville, NCNPI 1699430686
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.0% of the total across 319 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,854, more than ten times the $14 reported in 2022. Among adult health clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 319 payments — averaging $20.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- AstraZeneca$1K
- Jazz Pharmaceuticals Inc.$587
- Boehringer Ingelheim$476
- Regeneron Healthcare Solutions, Inc.$474
- Axsome Therapeutics, Inc.$391
- plus $2K from 22 others
What the payments were for
- Travel & lodging$2554%
- Food & beverage$6,16294%
- Education$1382%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 64 | $1,145 |
| AstraZeneca | 53 | $1,131 |
| Jazz Pharmaceuticals Inc. | 30 | $587 |
| Boehringer Ingelheim | 22 | $476 |
| Regeneron Healthcare Solutions, Inc. | 27 | $474 |
| Axsome Therapeutics, Inc. | 16 | $391 |
| Sanofi | 14 | $302 |
| Inspire Medical Systems, Inc. | 9 | $291 |
| Avadel CNS Pharmaceuticals, LLC | 10 | $233 |
| Insmed, Inc. | 11 | $221 |
| Harmony Biosciences LLC | 6 | $180 |
| Viatris Specialty LLC | 7 | $144 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $144 |
| Electromed, Inc. | 11 | $142 |
| Verona Pharma, Inc. | 6 | $130 |
| Sanofi-aventis U.S. LLC | 1 | $95 |
| Mylan Specialty L.p. | 4 | $84 |
| Inogen, Inc. | 5 | $78 |
| Philips North America LLC | 3 | $57 |
| United Therapeutics Corporation | 3 | $56 |
| Baxter Healthcare | 1 | $41 |
| Paratek Pharmaceuticals, Inc. | 2 | $30 |
| 3b Medical, Inc. | 1 | $28 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| Hikma Pharmaceuticals USA | 1 | $19 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $18 |
| CSL Behring | 1 | $18 |
| ANI Pharmaceuticals, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,555 in reported general payments places this provider in the 90th percentile of 614 adult health providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 386 | $316,352 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 178 | $128,925 |
| Breo ElliptaFluticasone/Vilanterol | 185 | $81,108 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 123 | $66,815 |
| NucalaMepolizumab | 12 | $51,363 |
| SymbicortBudesonide/Formoterol Fumarate | 117 | $36,770 |
| Spiriva RespimatTiotropium Bromide | 47 | $36,189 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 53 | $29,886 |
| Advair HfaFluticasone Propion/Salmeterol | 56 | $21,619 |
| Incruse ElliptaUmeclidinium Bromide | 20 | $9,799 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 353 | $9,760 |
| Pirfenidone | 14 | $9,381 |
| DuleraMometasone/Formoterol | 17 | $6,514 |
| Wixela InhubFluticasone Propion/Salmeterol | 72 | $5,759 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 45 | $5,524 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Nucala, Incruse Ellipta | $1,145 | $525,436726 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $1,131 | $165,695295 claims |
| Boehringer IngelheimSpiriva Respimat, Stiolto Respimat | $476 | $66,075100 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 614 adult health providers in North Carolina.
Other adult health in Kernersville
- Meredith DunzweilerKernersville$12K
- Robert DodgeRaleigh$311K
- Kimberly CampDurham$147K
- Henry VanpalaRaleigh$110K
- Jolene SpencerWashington$83K
- Felicia RichardsonGreenville$64K
- Anna BooneReidsville$51K
- Chaely MedleyChapel Hill$47K
- Ann ShumDurham$35K
- Amy HopkinsGreenville$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.